The Lieber Institute for Brain Development (LIBD), announced today that Andrew Maslan has been appointed as its Chief Financial Officer, a newly created position.
Mr. Maslan will lead all aspects of LIBD’s financial management, and will play a pivotal role in the organization’s business development efforts. With more than 20 years comprehensive financial and general business experience, including investor relations, capital raising, strategic planning and budgeting, licensing, mergers & acquisitions, commercial scale-up, financial reporting, and corporate governance, Mr. Maslan will provide strategic guidance to the LIBD leadership, and manage all aspects of the organization’s operational financial plans.
“The creation of the CFO position is an important milestone, reflective of the Institute’s significant growth and progress over the past three years,” said Dr. Daniel Weinberger, Director and Chief Executive Officer of LIBD. “The success of our mission, to develop deeper insight into the developmental origins of schizophrenia and other developmental brain disorders, in order to find new treatments for these conditions, requires steady leadership and a thoughtful fiscal strategy. We are delighted to welcome Andrew as a member of our executive team. His expertise will help to ensure our continued progress as we oversee our expanding list of partnerships and scientific projects.”
Before joining LIBD, Mr. Maslan served 8 years as CFO for Cytomedix, Inc., a publicly traded medical device/biotechnology company, where he was responsible for the full spectrum of financial and administrative functions, and integrally involved in all capital raising, M&A, licensing, and strategic planning activities. Prior to Cytomedix, Mr. Maslan served as Controller of BioReliance, and previously held various positions of increasing responsibility at GlobeTraders, Inc., Providence Laboratory Associates, and KPMG.
“I am extremely pleased to join such an impressive organization,” said Mr. Maslan. “It is an exciting time at LIBD, as we are leveraging the unprecedented founding donations from the Lieber and Maltz families through partnerships with industry, academia, government, and clinical operators.”
Mr. Maslan received his undergraduate degree in Accountancy from Miami University of Ohio and is licensed as a Certified Public Accountant in the state of Maryland.